eLife, the funder–researcher collaboration for the very best in science and science communication, is now accepting submissions for its much-anticipated new journal. The open-access eLife journal will be the keystone in the initiative’s efforts to lead change in scientific publishing.
First announced in summer 2011, eLife is a researcher-driven initiative backed by the Howard Hughes Medical Institute, the Max Planck Society, and the Wellcome Trust. eLife’s first aim is to launch an open-access journal for outstanding scientific advances that is also a platform for experimentation and showcasing innovation in research communication.
Beginning today, eLife invites submissions across the full breadth of life science and biomedicine – from the most basic and theoretical work through to translational, applied, and clinical research. eLife will publish the most influential findings – from advances in basic understanding to research with the potential to drive an entire field forward, and studies that demonstrate real-world outcomes.
“We’re offering authors a much-needed new venue for their most important discoveries,” said Randy Schekman, eLife Editor-in-Chief. “With the support of three prestigious biomedical research funders and led by 200 of the world’s most respected scientists, we believe eLife will quickly reach the forefront of scientific publishing. Now is the time for researchers to get on board and send their best work.”
In establishing a powerful presence in science publishing, the eLife initiative aims to lead change – to catalyse innovation in research communication through experimentation, collaboration, and continuous improvement. With the call for papers, eLife introduces a fresh approach to peer review and publication, in which decisions are swift and guidance to authors is concise and clear.
“All of our efforts are designed to put authors at the centre,” added Mark Patterson, eLife Managing Executive Editor. “The vetting and editorial process will be efficient and pain-free, and our approach to publishing will drive maximum possible exposure and use of every published article.” There is no cost to publish in eLife for an initial period.
The eLife journal is set for launch at the end of 2012. To submit and learn more about the initiative, visit http://www.elifesciences.org/send-your-papers-now.
# # #
Jennifer McLennan, eLife
j.mclennan [at] elifesciences [dot] org
eLife is a unique collaboration between the funders and practitioners of research to communicate ground-breaking discoveries in the life and biomedical sciences in the most effective way. Set for launch in late 2012, the eLife journal will be a platform for maximising the reach and influence of new discoveries and to showcase new approaches to the presentation, use, and assessment of research. As an open-access journal, eLife will deliver access to content for free, online, immediately on publication, and will encourage maximum possible reach and utility of the content by publishing under the terms of the Creative Commons Attribution License, which is emerging as the gold standard for open-access publishing. Learn more at elifesciences.org.